Exploring ONC201's unexpected efficacy against relapsed leukemias through DRD2 antagonism and mitochondrial targeting in clinical trials.
Discover how hypermethylation of HOX genes contributes to myeloid and lymphoid malignancies and impacts patient prognosis.